Comprehensive Care for Patients With ADHD:
A Practical, Interactive Initiative
| Wednesday, October 15, 2008 | Hyatt Regency Huntington Beach Resort & Spa |
| 6:15 PM – 7:00 PM Registration/Dinner | 21500 Pacific Coast Highway |
| 7:00 pm – 8:30 pm Scientific Session | Huntington Beach, California |
| Chair | Faculty Presenter |
| Timothy E. Wilens, MD | James T. McCracken, MD |
| Associate Professor, Psychiatry | Professor, Child Psychiatry |
| Harvard Medical School | David Geffen School of Medicine at UCLA |
| Director, Substance Abuse | Director, Division of Child and Adolescent Psychiatry |
| Pediatric Psychopharmacology Research Unit | UCLA Neuropsychiatric Institute and Hospital in Los Angeles |
| Massachusetts General Hospital | Los Angeles, California |
| Boston, Massachusetts |
STATEMENT OF NEED
Attention-deficit/hyperactivity disorder (ADHD) remains an undertreated and underrecognized disorder. Studies have shown that fewer than half of all children and adolescents who met DSM-IV criteria for ADHD had had a prior diagnosis, and fewer than a third of these had received medication for ADHD for most of the previous 12 months. Among adults, the situation is even worse, as the National Comorbidity Survey Replication reported that only about 11% of adults with ADHD received treatment for the disorder within the past 12 months. These data reinforce the ongoing need to educate clinicians concerning the recognition and treatment of ADHD in childhood, adolescence, and adulthood. This evening symposium will discuss the diagnosis and treatment of ADHD, with particular emphasis on the period from early adolescence to adulthood, through didactic presentation and case vignettes.
Intended Audience
Psychiatrists, primary care physicians, and
other health care providers who treat patients with ADHD
Accreditation/Designation Statements
Veritas Institute for Medical Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Veritas Institute for Medical Education, Inc. designates this educational activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Veritas Institute for Medical Education, Inc., 877-225-2927
Financial and Unlabeled Use Disclosures
The relevant financial relationships of those persons in a position to control the content of this CME activity will be disclosed at the meeting. Participants are advised that this CME activity will contain references to unlabeled/unapproved/investigational uses of drugs to treat ADHD.
Sponsorship and Support
Sponsored
by Veritas Institute for Medical Education, Inc.
Supported by an educational grant from McNeil Pediatrics Division of McNeil-PPC,
Inc.,
administered by Ortho-McNeil Janssen Scientific Affairs, LLC.
VIMHAK32-18